We are live on ! Find out more
BTX.WS

BioTime Inc Warrants (Expiring October 1, 2018)

Delisted

BTX.WS was delisted on the 26th of September, 2018.

37 hedge funds and large institutions have $635K invested in BioTime Inc Warrants (Expiring October 1, 2018) in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 4

16% more funds holding

Funds holding: 3237 (+5)

31% less capital invested

Capital invested by funds: $921K → $635K (-$286K)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
37
Holders Change
+5
Holders Change %
+15.63%
% of All Funds
1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
2
Reduced
6
Closed
4
Calls
$848K
Puts
Net Calls
+$848K
Net Calls Change
-$1.14M

BTX.WS Hedge Fund Activity: Q2 2015 in Review

37 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) for Q2 2015, worth a combined $635K — down 31% from $921K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new BTX.WS positions and 4 closed out — a net gain of 5 holders — while 2 added to existing stakes and 6 trimmed.

The largest buyer was Ionic Capital Management, opening a new position worth an estimated $512K. The largest seller was First Eagle Investment Management, exiting entirely with an estimated $362K sold.

  • 37 institutional investors held BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) as of Q2 2015, up from 32 in Q1 2015.
  • Funds reported $635K of BioTime Inc Warrants (Expiring October 1, 2018) stock for Q2 2015, down 31% quarter-over-quarter.
  • 9 funds opened new BioTime Inc Warrants (Expiring October 1, 2018) positions in Q2 2015 and 4 closed out, a net change of +5 holders.
  • The largest BioTime Inc Warrants (Expiring October 1, 2018) buyer in Q2 2015 was Ionic Capital Management, an estimated $512K added.
  • The largest BioTime Inc Warrants (Expiring October 1, 2018) seller in Q2 2015 was First Eagle Investment Management, an estimated $362K sold.

Based on aggregated 13F filings for Q2 2015.